Product Description
Product details
- Country of Origin : Made in India
- Shelf life : 36 MONTH
- Form : Tablet
- Packaging Size : 1*30
- Composition : Emtricitabine (200mg) + Tenofovir disoproxil fumarate (300mg) + Efavirenz (600mg)
Comprehensive HIV-1 TreatmentCipla Viraday is formulated to offer broad-spectrum antiretroviral therapy in a single tablet. Each dose combines three active ingredients to inhibit viral replication, supporting the immune system's function and overall health in adults living with HIV-1. Adherence to daily therapy is vital for treatment effectiveness and prevention of resistance.
Usage Guidelines and Safety PrecautionsViraday should be taken once daily at the same time, as prescribed by your physician. The tablet is suitable for oral administration and can be taken with or without food. Avoid use if you have known hypersensitivity to any ingredient. Side effects may include dizziness, rash, nausea, or headache. Please consult your doctor for comprehensive safety information.
Global Quality and PackagingManufactured in India and available worldwide, Viraday tablets are securely packaged in bottles of 30 tablets, ensuring optimal freshness and safety. The packaging is in English and includes a barcode for easy tracking. It carries a shelf life of 24 months from date of manufacture when stored correctly.
FAQ's of Cipla Viraday Tablets:
Q: How should Cipla Viraday Tablets be taken for optimal results?
A: Cipla Viraday Tablets should be taken orally, once per day, preferably at the same time each day, as directed by your physician. They can be consumed with or without food.
Q: What are the main benefits of using Viraday Tablets for HIV-1 infection?
A: Viraday Tablets help control HIV-1 infection by reducing viral replication, supporting immune health, and decreasing the risk of disease progression or transmission when used consistently as prescribed.
Q: When can I expect to notice improvements after starting Viraday therapy?
A: Improvements in viral load and immune response may be seen within several weeks to months of consistent daily use. Your doctor will monitor your progress through regular blood tests.
Q: What should I do if I experience side effects like dizziness or rash?
A: If you notice side effects such as dizziness, rash, nausea, or headache, promptly inform your healthcare provider. Do not discontinue medication without medical advice, as your doctor may adjust your treatment based on your symptoms.
Q: Where are Cipla Viraday Tablets manufactured and available?
A: Viraday is produced in India and is available for export and supply to international markets. The packaging is in English and includes a barcode for verification.
Q: What is the process for storing Cipla Viraday Tablets safely?
A: Store the tablets below 30C, in a dry place away from moisture. Always keep the tablets in their original bottle and out of reach of children to maintain their efficacy and lifespan.
Q: Who should avoid using Viraday Tablets?
A: Individuals with a known hypersensitivity to any of the active or inactive ingredients should not use Viraday. Consult your physician before starting any new medication to ensure it is appropriate for you.